The potential impact of post-COVID symptoms in the healthcare sector

被引:14
|
作者
Tempany, M. [1 ]
Leonard, A. [2 ,3 ,4 ]
Prior, A. R. [5 ]
Boran, G. [2 ,3 ,4 ]
Reilly, P. [2 ,3 ,4 ]
Murray, C. [2 ,3 ,4 ]
O'Brien, M. [2 ,3 ,4 ]
Maguire, G. [2 ,3 ,4 ]
Ennis, D. [2 ,3 ,4 ]
Rakovac, A. [2 ,3 ,4 ]
Reid, A. [1 ]
机构
[1] Tallaght Univ Hosp, Dept Occupat Hlth & Wellbeing, Dublin 24, Ireland
[2] Tallaght Univ Hosp, Dept Clin Chem, Dublin 24, Ireland
[3] Tallaght Univ Hosp, Dept Lab Med, Dublin 24, Ireland
[4] Trinity Coll Dublin, Sch Med, Dublin 2, Ireland
[5] Tallaght Univ Hosp, Dept Clin Microbiol, Dublin 24, Ireland
来源
OCCUPATIONAL MEDICINE-OXFORD | 2021年 / 71卷 / 6-7期
关键词
Healthcare worker; post-COVID syndrome; presenteeism; SARS-CoV-2; PRESENTEEISM; WORKERS;
D O I
10.1093/occmed/kqab109
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The phenomenon of post-COVID syndrome (PCS) is evolving from an abstract array of non-specific symptoms to an identifiable clinical entity of variable severity. Its frequency and persistence have implications for service delivery and workforce planning. Aims This study was aimed to assess the prevalence of symptoms consistent with PCS and the subjective degree of recovery in a cohort of healthcare workers, focusing on those who have returned to work. Methods A study population of 1176 was surveyed when attending for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody testing. Two sub-groups were identified: those with known (i.e. diagnosed on PCR testing) and assumed (i.e. antibody evidence of previous infection) SARs-CoV-2 infection, at least 12 weeks prior to the study. Each group was asked about their subjective degree of recovery and the nature of their persistent symptoms. Results were analysed via excel and SPSS. Results In total, 144 employees showed PCR evidence of previous infection, with 139 of these being infected at least 12 weeks prior to the study. Of these 139, only 19% (n = 26) reported feeling 100% recovered, and 71% reported persistent symptoms. Of those with assumed SARS-CoV-2 infection (n = 78), 32 (41%) were truly asymptomatic since the commencement of the pandemic, while 46 (59%) described symptoms suggestive of possible infection at least 12 weeks prior to the study. Of this latter group, 23% (n = 18) also reported residual symptoms. Conclusions PCS is prevalent among this group, including those not previously diagnosed with COVID-19. Its' frequency and duration present challenges to employers with regards to the management of work availability and performance.
引用
收藏
页码:284 / 289
页数:6
相关论文
共 50 条
  • [21] Pathophysiology of Post-COVID syndromes: a new perspective
    Batiha, Gaber El-Saber
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Welson, Nermeen N.
    VIROLOGY JOURNAL, 2022, 19 (01)
  • [22] Post-COVID syndrome: A reflection and opinion paper
    Bouza, Emilio
    Canton Moreno, Rafael
    De Lucas Ramos, Pilar
    Garcia-Botella, Alejandra
    Garcia-Lledo, Alberto
    Gomez-Pavon, Javier
    Gonzalez del Castillo, Juan
    Hernandez-Sampelayo, Teresa
    Cruz Martin-Delgado, Mari
    Martin Sanchez, Francisco Javier
    Martinez-Selles, Manuel
    Molero Garcia, Jose Maria
    Moreno Guillen, Santiago
    Javier Rodriguez-Artalejo, Francisco
    Ruiz-Galiana, Julian
    De Pablo Bruhlmann, Silvia
    Porta Etessam, Jesus
    Santos Sebastian, Mar
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (04) : 269 - 279
  • [23] Post-COVID Syndrome in Adults-An Overview
    Scharf, Ruediger E.
    Anaya, Juan-Manuel
    VIRUSES-BASEL, 2023, 15 (03):
  • [24] Mild post-COVID syndrome in young patients
    Ivchenko, Gleb S.
    Lobzhanidze, Natela N.
    Rusina, Daria S.
    Denisova, Evgeniya V.
    Ivchenko, Anna A.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (08) : 674 - 678
  • [25] Behandlung des schweren Post-Covid-SyndromsTreatment of severe post-COVID syndrome
    Kristina Adorjan
    Michael Ruzicka
    Gerardo Ibarra
    Hans Christian Stubbe
    MMW - Fortschritte der Medizin, 2023, 165 (1) : 52 - 57
  • [26] Neurological and psychiatric expert assessment of post-COVID syndrome
    Tegenthoff, M.
    Drechsel-Schlund, C.
    Widder, B.
    NERVENARZT, 2022, 93 (08): : 804 - 811
  • [27] HUMAN BODY RESISTANCE DYNAMICS IN THE POST-COVID PERIOD
    Zhdanova, E., V
    Rubtsova, E., V
    Kostolomova, E. G.
    INFEKTSIYA I IMMUNITET, 2024, 14 (04): : 747 - 755
  • [28] Proposal of a food supplement for the management of post-COVID syndrome
    Naureen, Z.
    Dautaj, A.
    Nodari, S.
    Fioretti, F.
    Dhuli, K.
    Anpilogov, K.
    Lorusso, L.
    Paolacci, S.
    Michelini, S.
    Guda, T.
    Kallazi, M.
    Bertelli, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 : 67 - 73
  • [29] First results from post-COVID inpatient rehabilitation
    Kupferschmitt, Alexa
    Langheim, Eike
    Tueter, Haris
    Etzrodt, Franziska
    Loew, Thomas H.
    Koellner, Volker
    FRONTIERS IN REHABILITATION SCIENCES, 2023, 3
  • [30] Immunoadsorption to treat patients with severe post-COVID syndrome
    Giszas, Benjamin
    Reuken, Philipp A. A.
    Katzer, Katrin
    Kiehntopf, Michael
    Schmerler, Diana
    Rummler, Silke
    Stallmach, Andreas
    Klink, Anne
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (04) : 790 - 801